Statistics

Total Visits

Views
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program111

Select a period of time:

Number of views in the range

Views
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program29

Views

Views
November 20252
December 20251
January 202615
February 20261
March 20266
April 20260
May 20264
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States16
Spain3
Ecuador2
Argentina2
Australia1
Canada1
China1
Ethiopia1
United Kingdom1
Mexico1
 

Top cities views

Views
San Jose10
A Coruña2
Addis Ababa1
Alcorta1
Cuenca1
Fredericton1
Greenville1
Machala1
Madrid1
Neuquén1